Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by Riverfolk

V.ARCH

Top 10 Undervalued Healthcare Sector Stocks

Globe and Mail Article

October 31, 2024

V.ARCH

Arch Biopartners - CEO adds 1% of outstanding shares

Over the past 2 months the CEO of Arch has excercised 550,000 options and...

May 25, 2024

V.ARCH

Arch BioPartners - LSALT Peptide Development

Arch believes that LSALT peptide has the potential to deliver a major...

March 18, 2024

V.ARCH

LSALT PEPTIDE - BRITISH MEDICAL JOURNAL PUBLICATION

Multicentre, randomized, double-blind, placebo-controlled, proof of concept...

March 18, 2024

V.ARCH

Arch Biopartners Cilistatin Breakthrough Article

Arch Biopartners Cilistatin Breakthrough

February 27, 2024

V.ARCH

Arch has Pre-IND Meeting with FDA - Cilistatin

Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing...

February 27, 2024

V.ARCH

Arch Receives Ethics Committee Approval in Turkey

Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed...

December 21, 2023

V.ARCH

Arch Submits Health Canada Phase II application

TORONTO, Dec.  13, 2023  (GLOBE NEWSWIRE) -- Arch Biopartners Inc.,...

December 13, 2023

V.ARCH

Arch Biopartners - Underlying Fundamentals

Arch Biopartners is a late stage clinical trail company focused on preventing...

November 10, 2023

V.ARCH

Arch Biopartners - LSALT Peptide

Warren Buffet - We do not feel richer or poorer based on what the stock does,...

November 4, 2023

V.ARCH

RE:News - ARCH BIOPARTNERS RECEIVES PERMISSION FROM U.S. FDA

Recent funding contribution from the National Research Council of Canada...

June 27, 2023

V.ARCH

News - ARCH BIOPARTNERS RECEIVES PERMISSION FROM U.S. FDA

June 27 (Reuters) - Arch Biopartners Inc: * ARCH BIOPARTNERS RECEIVES...

June 27, 2023

V.ARCH

RE:New Press Release - Arch Biopartners Receives Permission From U.S. FDA to Proceed With Phase II Acute Kidney Injury Trial

"The IND application included preclinical data, Phase I and Phase II...

June 27, 2023

V.ARCH

Reuters - Arch Biopartners

 Nice coverage by Reuters this morning:   * ARCH BIOPARTNERS...

April 18, 2023

V.ARCH

NEWS - ARCH receives positive results Human Trial

Arch Successfully completes dose escalation trial

April 18, 2023

V.ARCH

LSALT / Metablok Preclinical

Arch scientists have demonstrated Metablok’s ability to block the...

April 8, 2023

V.ARCH

LSALT / Metablok Background

Inflammation Based Disease Inflammation is a localized physical condition...

April 8, 2023

V.ARCH

dipeptidase-1 contribute to contrast-induced AKI

Renal immune surveillance and dipeptidase-1 contribute to contrast-induced...

April 8, 2023

V.ARCH

LSALT Peptide (Metablok) team – lead scientists

LSALT Peptide Team

April 8, 2023

V.ARCH

Dipeptidase-1 governs renal inflammation

Dipeptidase-1 governs renal inflammation during ischemia reperfusion injury...

April 8, 2023

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. V.AJA

AJA Health and Wellness Inc. is focused on health and wellness solutions. The Company is engaged in operating a telemedicine ... view more »